PRODUCT MONOGRAPH. HAVRIX hepatitis A vaccine, inactivated. Suspension This leaflet is part III of a three-part “Product Monograph”. HAVRIX, hepatitis A vaccine, is a sterile suspension containing formaldehyde – has resulted from the administration of any vaccine product. Havrix (Hepatitis A Vaccine, Inactivated) is a noninfectious hepatitis A vaccine .. NDC Package of 1 Prefilled Disposable Tip-Lok├ó Syringe.

Author: Kazigrel Akikree
Country: Gambia
Language: English (Spanish)
Genre: Health and Food
Published (Last): 28 August 2016
Pages: 170
PDF File Size: 19.81 Mb
ePub File Size: 13.67 Mb
ISBN: 730-7-17440-249-3
Downloads: 71415
Price: Free* [*Free Regsitration Required]
Uploader: Gorr

Storage of unopened vials: Havrix is available in vials havdix 2 types of prefilled syringes. Military and diplomatic personnel. Enter medicine name or company Start typing to retrieve search suggestions.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.

The use of this vaccine may be considered during pregnancy, if necessary. Subjects with chronic liver disease had a lower antibody response to Havrix than healthy subjects [see Clinical Studies Your Name Your name is required.

According to the guidelines for the prevention and treatment of opportunistic infections in HIV-infected adolescents and adults, assess the IgG antibody response to the hepatitis A vaccine, inactivated one month after vaccination, and revaccinate nonresponders.

Subscribe to receive email notifications whenever new articles are published. Specific guidelines for dosage adjustments in renal pacjage are not available; it packkage that no dosage adjustments are needed. When concomitant administration of other vaccines or immunoglobulin is required, they should be given with different syringes and at different injection sites.


Havrix (hepatitis A vaccine) dose, indications, adverse effects, interactions from

We do not record any personal information entered above. No cases occurred in vaccinees who received Havrix. To bookmark a medicine you must sign up and log in. Havrix Monodose can be given concomitantly with monovalent and combination vaccines comprised of measles, mumps, rubella and varicella. Continue typing packae refine. Skin and Subcutaneous Tissue Disorders: Immunisation should be postponed in subjects suffering from an acute severed febrile illness.

PDR Search

The results described above should be considered to apply only to immunocompetent adults. Hepatitis A virus inactivated 1,2.

These data are intended to guide healthcare professionals in case of temporary temperature excursion only. Passive immunoprophylaxis with immune globulins may be indicated for immunocompromised persons instead of, or in addition to, vaccination. Up to 3 additional cases of mild clinical illness may have occurred in vaccinees.

Havrix Monodose Vaccine – Summary of Product Characteristics (SmPC) – (eMC)

The manufacturer recommends administration of the vaccine to pregnant paackage only if clearly needed. Catch-up vaccination may occur in patients 2 years and older, with doses separated by 6 to 18 months. It is possible that subjects may be in the incubation period of a hepatitis A infection at the time of immunisation. Angioedema, erythema multiforme, hyperhidrosis.

For example immunisation should be considered for the following risk groups: Discard the vaccine if the content appears otherwise. Find out more here. Angioneurotic oedema Erythema multiforme Urticaria. When concomitant administration is considered necessary the vaccines must insrt given at different injection sites. Qualitative and quantitative composition 3. Stimulation of specific antibodies takes place without producing any disease symptoms.


Havrix Rating No reviews – Add your review. The efficacy of the vaccine for postexposure prophylaxis harvix unknown in patients older knsert 40 years.

In order to obtain more persistent immunity, a booster padkage is recommended between 6 and 12 months after primary immunisation. Administer a booster dose at least 6 months after the first dose to complete the series.

Solicited general adverse events were reported as follows among children who received the first dose of Havrix coadministered with pneumococcal 7-valent conjugate vaccine: Swelling at the site of injection was the next most frequently reported reactions.

With thorough agitation, Havrix is a homogeneous, turbid, white suspension. Attenuated antibody responses to tetanus toxoid-containing vaccine, pneumococcal polysaccharide and pneumococcal conjugate vaccines, and seasonal influenza vaccine were observed in patients exposed to ocrelizumab at the time of vaccination during an open-label study.

It is not known whether Havrix is excreted in human milk. Breast-feeding It is unknown whether this vaccine is excreted in human milk. Hypersensitivity to the hvrix substance, to any of the excipients listed in section 6.

In adults, the injection should be given in the deltoid region. One month after a booster dose given 6 months after dose 1, seroconversion rates were similar among groups.

Medically reviewed on Jan 1, If either of these conditions exists, the vaccine should not be administered.